Kenji Yanashima
YOU?
Author Swipe
View article: Generation of iPSC-derived CD4<sup>+</sup>Th1 cells enhancing chimeric antigen receptor-T cell cytotoxicity
Generation of iPSC-derived CD4<sup>+</sup>Th1 cells enhancing chimeric antigen receptor-T cell cytotoxicity Open
Summary CD4 + T cells are anticipated to enhance the overall immune response, including the anti-tumor activity of chimeric antigen receptor (CAR)-T cell therapy. In the past, we established a culture system to generate CD8 + T cells from …
View article: Chromosomal Abnormalities as a Predisposition to Secondary Neurolymphomatosis in Patients with Diffuse Large B-Cell Lymphoma: A Report of Two Cases and a Literature Review
Chromosomal Abnormalities as a Predisposition to Secondary Neurolymphomatosis in Patients with Diffuse Large B-Cell Lymphoma: A Report of Two Cases and a Literature Review Open
Introduction: Neurolymphomatosis (NL) is a rare condition characterized by the infiltration of malignant lymphoma cells into the peripheral nervous system. The optimal treatment for NL remains unclear, and patients with secondary NL have a…